The modulation of orexin A on HCN currents of pyramidal neurons in mouse prelimbic cortex

Cereb Cortex. 2010 Jul;20(7):1756-67. doi: 10.1093/cercor/bhp241. Epub 2009 Nov 13.

Abstract

The hyperpolarization-activated/cyclic nucleotide (HCN)-gated channels make important contributions to neural excitability. In prefrontal cortex, HCN channels are localized on the distal dendrites of layer V pyramidal neurons and decrease neural excitability when they are open. In the present study, using whole-cell voltage clamp recordings, the effect of an arousal peptide, orexin A, on HCN currents in layer V pyramidal neurons from mouse prelimbic cortex (PL), the homolog of the prefrontal cortex was investigated. The results demonstrated that orexin A suppressed HCN currents and shifted their activation curve to a more negative direction. This action of orexin A was blocked by SB334867, an orexin receptor 1 (OXR1) blocker and bisindolylmaleimide, a protein kinase C (PKC) inhibitor, indicating the involvement of OXR1 and PKC. The excitatory effect of orexin A on PL pyramidal neurons was enhanced when HCN currents were diminished, while attenuated when HCN currents were enlarged. In summary, orexin A inhibits HCN currents and enhances excitability of pyramidal neurons in PL, which may contribute to arousal and cognition.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 8-Bromo Cyclic Adenosine Monophosphate / pharmacology
  • Animals
  • Animals, Newborn
  • Benzoxazoles / pharmacology
  • Biophysics / methods
  • Cerebral Cortex / cytology*
  • Cyclic Nucleotide-Gated Cation Channels / antagonists & inhibitors
  • Cyclic Nucleotide-Gated Cation Channels / metabolism*
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Electric Stimulation / methods
  • In Vitro Techniques
  • Intracellular Signaling Peptides and Proteins / pharmacology*
  • Membrane Potentials / drug effects
  • Mice
  • Mice, Inbred Strains
  • Naphthyridines
  • Neuropeptides / pharmacology*
  • Neurotransmitter Agents / pharmacology*
  • Orexin Receptors
  • Orexins
  • Patch-Clamp Techniques
  • Pyramidal Cells / drug effects*
  • Pyrimidines / pharmacology
  • Receptors, G-Protein-Coupled / metabolism
  • Receptors, Neuropeptide / metabolism
  • Sodium Channel Blockers / pharmacology
  • Tetrodotoxin / pharmacology
  • Urea / analogs & derivatives
  • Urea / pharmacology

Substances

  • 1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl urea
  • Benzoxazoles
  • Cyclic Nucleotide-Gated Cation Channels
  • Intracellular Signaling Peptides and Proteins
  • Naphthyridines
  • Neuropeptides
  • Neurotransmitter Agents
  • Orexin Receptors
  • Orexins
  • Pyrimidines
  • Receptors, G-Protein-Coupled
  • Receptors, Neuropeptide
  • Sodium Channel Blockers
  • ICI D2788
  • 8-Bromo Cyclic Adenosine Monophosphate
  • Tetrodotoxin
  • Urea